245 related articles for article (PubMed ID: 34877074)
1. Risk Factors and Diagnosis of Advanced Cutaneous Squamous Cell Carcinoma.
Brancaccio G; Briatico G; Pellegrini C; Rocco T; Moscarella E; Fargnoli MC
Dermatol Pract Concept; 2021 Nov; 11(Suppl 2):e2021166S. PubMed ID: 34877074
[TBL] [Abstract][Full Text] [Related]
2. Risk Factors for Cutaneous Squamous Cell Carcinoma Recurrence, Metastasis, and Disease-Specific Death: A Systematic Review and Meta-analysis.
Thompson AK; Kelley BF; Prokop LJ; Murad MH; Baum CL
JAMA Dermatol; 2016 Apr; 152(4):419-28. PubMed ID: 26762219
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology of advanced cutaneous squamous cell carcinoma.
Dessinioti C; Pitoulias M; Stratigos AJ
J Eur Acad Dermatol Venereol; 2022 Jan; 36(1):39-50. PubMed ID: 34592000
[TBL] [Abstract][Full Text] [Related]
4. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Concetta Fargnoli M; Forsea AM; Frenard C; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NWJ; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():83-102. PubMed ID: 32113942
[TBL] [Abstract][Full Text] [Related]
5. European consensus-based interdisciplinary guideline for invasive cutaneous squamous cell carcinoma: Part 2. Treatment-Update 2023.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; van Akkooi A; Bataille V; Bastholt L; Dreno B; Dummer R; Fargnoli MC; Forsea AM; Harwood CA; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Lallas A; Leiter U; Malvehy J; Del Marmol V; Moreno-Ramirez D; Pellacani G; Peris K; Saiag P; Tagliaferri L; Trakatelli M; Ioannides D; Vieira R; Zalaudek I; Arenberger P; Eggermont AMM; Röcken M; Grob JJ; Lorigan P;
Eur J Cancer; 2023 Nov; 193():113252. PubMed ID: 37708630
[TBL] [Abstract][Full Text] [Related]
6. Cutaneous Squamous Cell Carcinoma: A Review of High-Risk and Metastatic Disease.
Burton KA; Ashack KA; Khachemoune A
Am J Clin Dermatol; 2016 Oct; 17(5):491-508. PubMed ID: 27358187
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis and treatment of invasive squamous cell carcinoma of the skin: European consensus-based interdisciplinary guideline.
Stratigos A; Garbe C; Lebbe C; Malvehy J; del Marmol V; Pehamberger H; Peris K; Becker JC; Zalaudek I; Saiag P; Middleton MR; Bastholt L; Testori A; Grob JJ; ; ;
Eur J Cancer; 2015 Sep; 51(14):1989-2007. PubMed ID: 26219687
[TBL] [Abstract][Full Text] [Related]
8. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study.
Schmults CD; Karia PS; Carter JB; Han J; Qureshi AA
JAMA Dermatol; 2013 May; 149(5):541-7. PubMed ID: 23677079
[TBL] [Abstract][Full Text] [Related]
9. Response of advanced cutaneous squamous cell carcinoma to immunotherapy: case report.
Ashraf S; Alsharedi M
Stem Cell Investig; 2021; 8():19. PubMed ID: 34631872
[TBL] [Abstract][Full Text] [Related]
10. European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention.
Stratigos AJ; Garbe C; Dessinioti C; Lebbe C; Bataille V; Bastholt L; Dreno B; Fargnoli MC; Forsea AM; Frenard C; Harwood CΑ; Hauschild A; Hoeller C; Kandolf-Sekulovic L; Kaufmann R; Kelleners-Smeets NW; Malvehy J; Del Marmol V; Middleton MR; Moreno-Ramirez D; Pellecani G; Peris K; Saiag P; van den Beuken-van Everdingen MHJ; Vieira R; Zalaudek I; Eggermont AMM; Grob JJ;
Eur J Cancer; 2020 Mar; 128():60-82. PubMed ID: 32113941
[TBL] [Abstract][Full Text] [Related]
11. Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma.
Szewczyk M; Pazdrowski J; Golusiński P; Dańczak-Pazdrowska A; Marszałek S; Golusiński W
Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):3007-12. PubMed ID: 25217080
[TBL] [Abstract][Full Text] [Related]
12. Identifying candidates for immunotherapy with cemiplimab to treat advanced cutaneous squamous cell carcinoma: an expert opinion.
Argenziano G; Fargnoli MC; Fantini F; Gattoni M; Gualdi G; Pastore F; Pellacani G; Quaglino P; Queirolo P; Troiani T
Ther Adv Med Oncol; 2022; 14():17588359211066272. PubMed ID: 35035534
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous squamous cell carcinoma: Management of advanced and high-stage tumors.
Que SKT; Zwald FO; Schmults CD
J Am Acad Dermatol; 2018 Feb; 78(2):249-261. PubMed ID: 29332705
[TBL] [Abstract][Full Text] [Related]
14. Multidisciplinary management of locally advanced and metastatic cutaneous squamous cell carcinoma.
Claveau J; Archambault J; Ernst DS; Giacomantonio C; Limacher JJ; Murray C; Parent F; Zloty D
Curr Oncol; 2020 Aug; 27(4):e399-e407. PubMed ID: 32905333
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in the Diagnosis and Management of High-Risk Cutaneous Squamous Cell Carcinoma.
Dessinioti C; Stratigos AJ
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884616
[TBL] [Abstract][Full Text] [Related]
16. Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: The Current and Future Role of Radiation Therapy in the Era of Immunotherapy.
Ferini G; Palmisciano P; Forte S; Viola A; Martorana E; Parisi S; Valenti V; Fichera C; Umana GE; Pergolizzi S
Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454779
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.
Jambusaria-Pahlajani A; Kanetsky PA; Karia PS; Hwang WT; Gelfand JM; Whalen FM; Elenitsas R; Xu X; Schmults CD
JAMA Dermatol; 2013 Apr; 149(4):402-10. PubMed ID: 23325457
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for lymph node metastasis in cutaneous squamous cell carcinoma: a long-term retrospective study of Japanese patients.
Saito Y; Fujikawa H; Takatsuka S; Abe R; Takenouchi T
Int J Clin Oncol; 2021 Mar; 26(3):606-612. PubMed ID: 33175299
[TBL] [Abstract][Full Text] [Related]
19. A Sensitivity Meta-Analysis of Disease-Specific Death in Localized Cutaneous Squamous Cell Carcinoma.
Dessinioti C; Platsidaki E; Stratigos AJ
Dermatology; 2022; 238(6):1026-1035. PubMed ID: 35550380
[TBL] [Abstract][Full Text] [Related]
20. Identifying risk factors for the prognosis of head and neck cutaneous squamous cell carcinoma: A systematic review and meta-analysis.
Zeng S; Fu L; Zhou P; Ling H
PLoS One; 2020; 15(9):e0239586. PubMed ID: 32991600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]